- Home
- RPRX vs PHYS Comparison
RPRX vs PHYS Comparison
Compare RPRX & PHYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- PHYS
- Stock Information
- Founded
- RPRX 1996
- PHYS N/A
- Country
- RPRX United States
- PHYS
- Employees
- RPRX N/A
- PHYS N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- PHYS
- Sector
- RPRX Health Care
- PHYS
- Exchange
- RPRX Nasdaq
- PHYS NYSE
- Market Cap
- RPRX 13.9B
- PHYS 11.9B
- IPO Year
- RPRX 2020
- PHYS N/A
- Fundamental
- Price
- RPRX $36.46
- PHYS $25.54
- Analyst Decision
- RPRX Strong Buy
- PHYS
- Analyst Count
- RPRX 3
- PHYS 0
- Target Price
- RPRX $47.33
- PHYS N/A
- AVG Volume (30 Days)
- RPRX 4.4M
- PHYS N/A
- Earning Date
- RPRX 08-07-2025
- PHYS N/A
- Dividend Yield
- RPRX 2.42%
- PHYS N/A
- EPS Growth
- RPRX 37.60
- PHYS N/A
- EPS
- RPRX 2.45
- PHYS N/A
- Revenue
- RPRX $2,263,845,000.00
- PHYS N/A
- Revenue This Year
- RPRX $29.35
- PHYS N/A
- Revenue Next Year
- RPRX $7.58
- PHYS N/A
- P/E Ratio
- RPRX $14.83
- PHYS N/A
- Revenue Growth
- RPRX 1.13
- PHYS N/A
- 52 Week Low
- RPRX $24.05
- PHYS N/A
- 52 Week High
- RPRX $36.43
- PHYS N/A
- Technical
- Relative Strength Index (RSI)
- RPRX 64.64
- PHYS 51.05
- Support Level
- RPRX $35.01
- PHYS $24.86
- Resistance Level
- RPRX $36.33
- PHYS $25.72
- Average True Range (ATR)
- RPRX 0.63
- PHYS 0.21
- MACD
- RPRX 0.05
- PHYS -0.05
- Stochastic Oscillator
- RPRX 90.72
- PHYS 44.23
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About PHYS SPROTT PHYSICAL GOLD TRUST
Sprott Physical Gold Trust is a closed-end mutual fund trust. The company provides a secure, convenient and exchange-traded investment alternative for investors interested in holding physical gold bullion without the inconvenience associated with direct investment in physical gold bullion. The company invests mainly in long-term holdings of unencumbered, fully allocated, physical gold bullion and does not and will not speculate about short-term changes in gold prices.